Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Cantor Fitzgerald Initiates Coverage On Oncolytics Biotech with Overweight Rating, Announces Price Target of C$9

Cantor Fitzgerald Initiates Coverage On Oncolytics Biotech with Overweight Rating, Announces Price Target of C$9

Cantor Fitzgerald analyst Louise Chen initiates coverage on Oncolytics Biotech (TSX:ONC) with a Overweight rating and announces Price Target of C$9.

byBenzinga Newsdesk

March 6, 2023

1 minute read

Cantor Fitzgerald analyst Louise Chen initiates coverage on Oncolytics Biotech (TSX:ONC) with a Overweight rating and announces Price Target of C$9.

BigCommerce Announces Travis Hess Hired As Company President

By Benzinga Newsdesk

May 6, 8:13 AM

Former Accenture ecommerce leader brings expertise in solution selling, services, implementation and ecosystem partnerships to drive go-to-market transformation and operationsBigCommerce (NASDAQ:BIGC), an open SaaS,

BIGC

Why Are Shineco Shares Trading Higher Today?

By Vandana Singh

July 10, 2:53 PM

Shineco Inc (NASDAQ: SISI) shares are trading higher after its subsidiary, Changzhou Biowin Pharmaceutical Co Ltd, received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of the National Medical

SISI